Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | GRK5 |
| Upstream (Parents) |
|---|
| (<<) ATP2A2 → GRK5 |
| (<<) INPP5D → GRK5 |
| (<<) JAK3 → GRK5 |
| (<<) LTB → GRK5 |
| (<<) MAPKAP1 → GRK5 |
| (<<) MMP17 → GRK5 |
| (<<) NR3C1 → GRK5 |
| (<<) PLA2G4A → GRK5 |
| (<<) PPIF → GRK5 |
| (<<) PRKCB → GRK5 |
| (<<) RAP1A → GRK5 |
| (<<) SH3KBP1 → GRK5 |
| (<<) STX12 → GRK5 |
| (<<) TCF4 → GRK5 |
| (<<) TUBB2C → GRK5 |
| (<<) UBE2N → GRK5 |
| Downstream (Children) |
|---|
| GRK5 → ANKDD1A (>>) |
| GRK5 → ARSD (>>) |
| GRK5 → BBS1 (>>) |
| GRK5 → BCL2 (>>) |
| GRK5 → CCDC3 (>>) |
| GRK5 → CDK4 (>>) |
| GRK5 → CLEC2B (>>) |
| GRK5 → CTRB2 (>>) |
| GRK5 → CXCL14 (>>) |
| GRK5 → DLX2 (>>) |
| GRK5 → DNAJA4 (>>) |
| GRK5 → ETS1 (>>) |
| GRK5 → FGF7 (>>) |
| GRK5 → FGFBP1 (>>) |
| GRK5 → FOXC2 (>>) |
| GRK5 → HDAC9 (>>) |
| GRK5 → HS2ST1 (>>) |
| GRK5 → HSPA9 (>>) |
| GRK5 → IL18 (>>) |
| GRK5 → KREMEN1 (>>) |
| GRK5 → KRT14 (>>) |
| GRK5 → LIG1 (>>) |
| GRK5 → MBOAT2 (>>) |
| GRK5 → MEX3D (>>) |
| GRK5 → MRAS (>>) |
| GRK5 → MST1R (>>) |
| GRK5 → PAG1 (>>) |
| GRK5 → POP1 (>>) |
| GRK5 → PPP3CC (>>) |
| GRK5 → RPL26L1 (>>) |
| GRK5 → RPS28 (>>) |
| GRK5 → SGK1 (>>) |
| GRK5 → SLC5A1 (>>) |
| GRK5 → SLC6A14 (>>) |
| GRK5 → STK17A (>>) |
